Clinical Physiology of Circulation
ISSN 1814-6910 (Print)
ISSN 2410-9134 (Online)
Chief Editor
Leo A. Bockeria, MD, PhD, DSc, Professor, Academician of Russian Academy of Sciences, President of Bakoulev National Medical Research Center for Cardiovascular Surgery
Sort by
Acute liver failure etiology and pathogenesis
Authors:
Company:
A.N. Bakoulev Scientific Center for Cardiovascular Surgery, Ministry of Health of the Russia,
Rublevskoe shosse, 135, Moscow, 121552, Russian Federation
E-mail: Сведения доступны для зарегистрированных пользователей.
UDC: 616.36-002.4-008.64
Link: Clinical Physiology of Blood Circulaiton. 2016; 13 (2): 75-84
Quote as: Yaroustovsky M.B., Abramyan M.V., Komardina E.V. Acute liver failure etiology and pathogenesis. Klinicheskaya Fiziologiya Krovoobrashcheniya (Clinical Physiology of Circulation, Russian journal). 2016; 13 (2): 75-84 (in Russ.).
Received / Accepted: 26.05.2016/29.05.2016
Abstract
Acute liver failure usually develops in multiple organ dysfunction syndrome and carries a high mortality. This review represents recent data of acute liver failure etiology and pathogenesis: endogenous intoxication syndrome, hepatic encephalopathy, system inflammatory response, hepatorenal syndrome and hemostatic disorders were considered. There was also reviewed the conception of acute liver failure in sepsis and hypoxic hepatitis. Understanding of acute liver failure mechanisms allows to optimize the treatment approach.References
1. O'Grady J.G. Acute liver failure. J. Postgrad. Med. 2005; 81: 148-54.
2. Larson A.M. Diagnosis and management of acute liver failure. Cun: Opin. Gastroenterol. 2010; 26: 214—21.
3. Bernal W, Auzinger G., Dhawan A., Wendon J. Acute liver failure. Lancet. 2010; 376: 190—201.
4. Lee W.M. Etiologies of acute liver failure. Semin. Liver. Dis. 2008; 28: 142-52.
5. Mauss S., Berg T., Rockston J., Sarrazin C., Wedemeyer H. Hepatology: A clinical textbook. 6th edition. Flying Publisher; 2015.
6. Hadem J., Tacke F., Bruns T Etiologies and outcomes of acute liver failure in Germany. Clin. Gastroenterol. Hepatol. 2012; 10: 664-9.
7. Hussaini S.H., Farrington E.A. Idiosyncratic drug- induced liver injury: an overview. Expert Opin. Drug. Saf. 2007; 6 (6): 673-84.
8. Metushi I.G., Sanders C. Acute Liver Study Group. Detection of anti-isoniazid and anti-cytochrome P450 antibodies in patients with isoniazid-induced liver failure. Hepatology. 2014; 59 (3): 1084—93.
9. Amathieu R., Levesque E., Merle J.C. et al. Severe toxic acute liver failure: etiology and treatment. Ann. Fr. Anesth. Reanim. 2013; 32 (6): 416—21.
10. Pischke S., Behrendt R, Bock C.T et al. Hepatitis E in Germany — an under-reported infectious disease. Detsch ArzteblInt. 2014; ill (35-36): 577-83.
11. Manka R, Bechmann L.P, Coombes J.D. et al. Hepatitis E Virus Infection as a Possible Cause of Acute Liver Failure in Europe. Clin. Gastroenterol. Hepatol. 2015; 13 (10): 1836-42.
12. Crossan C.L., Simpson K.J., Craig D.G. et al. Hepatitis E virus in patients with acute severe liver injury. World J. Hepatol. 2014; 6 (6): 426-34.
13. Kathemann S., Bechmann L.P, Sowa J.P. et al. Etiology, outcome and prognostic factors of childhood acute liver failure in a German Single Center. Ann. Hepatol. 2015; 14 (5): 722-8.
14. Schwarz K.B., Dell Olio D., Lobritto S.J. et al. Pediatric Acute Liver Failure Study Group. Analysis of viral testing in nonacetaminophen pediatric acute liver failure. J. Pediatr. Gastroenterol. Nutr. 2014; 59 (5): 616-23.
15. Hegarty R., Hadzic N., Gissen P, Dhawan A. Inherited metabolic disorders presenting as acute liver failure in newborns and young children: King's College Hospital experience. Eur. J. Pediatr. 2015; 174 (10): 1387—92.
16. Sundaram S.S., Alonso E.M., Narkewicz M.R. et al. Pediatric Acute Liver Failure Study Group. Characterization and outcomes of young infants with acute liver failure. J. Pediatr. 2011; 159 (5): 813—8.
17. Ramah J.S., Kazuhiro K., Morimatsu H. et al. Severe ischemic early liver injury after cardiac surgery. Ann. Thorac. Surg. 2002; 74: 1601—6.
18. Coralli R.J., Crawley I.S. Hepatic pulsations in constrictive pericarditis. Am. J. Cardiol 1986; 58: 370.
19. Bernal W, Hyyrylainen A., Gera A., AudimoolamV.K., McPhail M.J., Auzinger G. et al. Lessons from lookback in acute liver failure? A single centre experience of 3300 patients. J. Hepatol. 2013; 59 (1): 74—80.
20. Jaeschke H., Lie J. Neutrophil depletion protects against murine acetaminophen hepatotoxicity: another perspective. Hepatology. 2007; 45: 1588—9.
21. Basile A.S., Harrison P.M., Hughes R.D. et al. Relationship between plasma benzodiazepine receptor ligand concentrations and severity of hepatic encephalopathy. Hepatology. 1994; 19: 112—21.
22. Schafer D.F., Jones E.A. Hepatic encephalopathy and the gamma-amino-butyric acid neurotransmitter system. Lancet. 1982; 11: 18—20.
23. Pemey R, Butterworth R.F., Mousseau D.D. et al. Plasma and CSF benzodiazepine receptor ligand concentrations in cirrhotic patients with hepatic encephalopathy: relationship to severity of enca- phalopathy and pharmaceutical benzodiazepine intake. Metab. Brain. Dis. 1998; 13: 201—10.
24. Oettl K., Bimer-Gruenberger R., Spindelboeck W et al. Oxidative albumin damage in chronic liver failure: relation to albumin binding capacity, liver dysfunction and survival. J. Hepatol. 2013; 59 (5): 978—83.
25. Clemmesen O. Splanchnic circulation and metabolism in patients with acute liver failure. Dan. Med. Bull. 2002; 49 (3): 177-93.
26. Etogo-Asse F.E., Vincent R.P., Hughes S.A. High density lipoprotein in patients with liver failure; relation to sepsis, adrenal function and outcome of illness. Liver Int. 2012; 32: 128-36.
27. Manka R, Olliges V., Bechmann L.P. et al. Low levels of blood lipids are associated with etiology and letal outcome in acute liver failure. PLoS. One. 2014; 9 (7).
28. Aronson L., Gacad R.C., Kaminsky-Russ K. Evidence gut production of endogenous benzodiazepines: implications for hepatic encephalopathy. Gastroenterology. 1996; 110: 1144.
29. O'Grady J.G., Schalm S.W., Williams R. Acute liver failure: redefining the syndromes. Lancet. 1993; 342: 273-5.
30. Jayakumar A.R., Rama Rao K.V., Norenberg M.D. Neuroinflammation in hepatic encephalopathy: mechanistic aspects. I. Clin. Exp. Hepatol. 2015; 5 (Suppl. 1): S21-8.
31. Chastre A., Belanger M., Beauchesne E. et al. Inflammatory cascades driven by tumor necrosis factor-alpha play a major role in the progression of acute Uver failure and its neurological complications. PLoS One. 2012; 7 (11).
32. Jiang W., Desjardins R, Butterworth R.F. Cerebral inflammation contributes to encephalopathy and brain edema in acute liver failure: protective effect of minocycline. I. Neurochem. 2009; 109 (2): 485—93.
33. Bemeur C., Butterworth R.F. Liver-brain proinflammatory signalling in acute liver failure: role in the pathogenesis of hepatic encephalopathy and brain edema. Metab. Brain. Dis. 2013; 28 (2): 145—50.
34. Butterworth R.F. The liver-brain axis in liver failure: neuroinflammation and encephalopathy. Nat. Rev. Gastroenterol. Hepatol. 2013; 10 (9): 522—8.
35. Shawcross D.L., Wendon J.A. The neurological manifestations of acute liver failure. Neurochem. Int. 2012; 60 (7): 662-71.
36. Taylor N.J., Nishtala A., Manakkat Vijay G.K. et al. Circulating neutrophil dysfunction in acute liver failure. Hepatology. 2013; 57 (3): 1142-52.
37. Rule J.A., Hynan L.S., Attar N. et al. Acute Liver Failure Study Group. Procalcitonin identifies cell injury, not bacterial infection, in acute liver failure. PLoS One. 2015; 10(9).
38. Mahmoud Abu-Amara, Shi Yu Yang, Alexander Seifalian et al. The nitric oxide pathway — evidence and mechanisms for protection against liver ischaemia reperfusion injury. Liver Int. 2012; 32 (4): 531—43.
39. Urrunaga N.H., Magder L.S., Weir M.R. et al. Prevalence, Severity, and Impact of Renal Dysfunction in Acute Liver Failure on the US Liver Transplant Waiting List. Dig. Dis. Sci. 2016; 61 (1): 309-16.
40. Pillebout E. Diagnosis and therapy of the hepatorenal syndrome. Dtsch. Med. Wochenschr. 2015; 140 (14): 1083-90.
41. Saracyn M., Z^bkowski T, Zdanowski R. et al. Effect of nitric oxide pathway regulation on water/sodium balance and renal function in a rodent model of acute liver and renal failure. Med. Sci. Monit. 2014; 20: 1735—44.
42. Romano T.G., Vieira J.M. Jr. Do Biliary Salts Have Role on Acute Kidney Injury Development? I. Clin. Med. Res. 2015; 7 (9): 667-71.
43. Zager R.A., Johnson A.C., Frostad KB. Acute hepatic ischemic-reperfusion injury induces a renal cortical "stress response", renal "cytoresistance", and an endotoxin hyperresponsive state. Am. J. Physiol. Renal. Physiol. 2014; 307 (7): 856-68.
44. Angeli P, Morando E, Cavallin M., Piano S. Hepatorenal syndrome. Contrib. Nephrol. 2011; 174: 46-55.
45. Lisman T, Caldwell S.H., Burroughs A.K. et al. Coagulation in Liver Disease Study Group. Hemostasis and thrombosis in patients with liver disease: the ups and downs. I. Hepatol. 2010; 53 (2): 362—71.
46. Northup P.G., Caldwell S.H. Coagulation in liver disease: a guide for the clinician. Clin. Gastroenterol. Hepatol. 2013; 11 (9): 1064-74.
47. Lisman T, Stravitz R.T Rebalanced Hemostasis in Patients with Acute Liver Failure. Semin. Thromb. Hemost. 2015; 41 (5): 468-73.
48. Hugenholtz G.C., Adelmeijer J., Meijers J.C. et al. An unbalance between von Willebrand factor and ADAMTS13 in acute liver failure: implications for hemostasis and clinical outcome. Hepatology. 2013; 58 (2): 752-61.
49. Audimoolam V.K., McPhail M.J., Wendon J.A. et al. Lung injury and its prognostic significance in acute liver failure. Grit. Care Med. 2014; 42 (3): 592-600.
50. Patel J.J., Taneja A., Niccum D. et al. The association of serum bilirubin levels on the outcomes of severe sepsis. I. Intensive Care Med. 2015; 30 (1): 23-9.
51. Nesseler N., Launey Y, Aninat C. et al. Clinical review: the liver in sepsis. Crit. Care. 2012; 16 (5): 235.
52. Stutchfield B.M., Antoine D.J., Mackinnon A.C. et al. CSF1 Restores Innate Immunity Following Liver Injury in Mice and Serum Levels Indicate Outcomes of Patients with Acute Liver Failure. Gastroenterology. 2015; 149 (7): 1896-1909.
53. Zhang S., Yang N., Ni S. et al. Pretreatment of lipopolysaccharide (LPS) ameliorates D-GalN/LPS induced acute liver failure through TLR4 signaling pathway. Int. I. Clin. Exp. Pathol. 2014; 7 (10): 6626-34.
54. Kono T, Kotani H., Asama T. et al. Protective effect of pretreatment with low-dose lipopolysaccharide on D-galactosamine-induced acute liver failure. Int. I. Colorectal. Dis. 2002; 17 (2): 98-103.
55. Sun S., Guo Y., Zhao G. et al. Complement and the alternative pathway play an important role in LPS/D- GalN-induced fulminant hepatic failure. PLoS One. 2011; 6(11).
56. Tapper E.B., Sengupta N., Bonder A. The Incidence and Outcomes of Ischemic Hepatitis: A Systematic Review with Meta-Analysis. Am. I. Med. 2015; 128 (12): 1314-21.
57. Taylor R.M., Tujios S., Jinjuvadia K. et al. Short and long-term outcomes in patients with acute liver failure due to ischemic hepatitis. Dig. Dis. Sci. 2012; 57 (3): 777-85.
58. Henrion J. Hypoxic hepatitis. Liver Int. 2012; 32 (7): 1039-52.
59. Zhang J., Qian H.G., Leng J.H. et al. Ischemic liver injury after complete occlusion of hepatic artery in the treatment of delayed postoperative arterial bleeding. I. Gastrointest. Surg. 2015; 2.
60. Puviani L., Cavallari G., Bonaiuto E. et al. Portal blood arterialization with an extracorporeal device to treat toxic acute hepatic failure in a swine model. Int. I. Artif. Organs. 2014; 37 (11): 847-53.
61. Zullo A., Cannistra M., Cavallari G. et al. Liver Regeneration Induced By Extracorporeal Portal Vein Arterialization in a Swine Model of Carbon Tetrachloride Intoxication. Transplant Proc. 2015; 47 (7): 2173-5.
62. Datta G., Fuller B.J., Davidson B.R. Molecular mechanisms of liver ischemia reperfusion injury: insights from transgenic knockout models. World I. Gastroenterol. 2013; 19 (11): 1683-98.
63. Zhang J., Hu W, Xing W et al. The protective role of CD59 and pathogenic role of complement in hepatic ischemia and reperfusion injury. Am. I. Pathol. 2011; 179 (6): 2876-84.
64. Saidi R.F., Rajeshkumar B., Shariftabrizi A. et al. Human Cl inhibitor attenuates liver ischemia-reperfusion injury and promotes liver regeneration. I. Surg. Res. 2014; 187 (2): 660-6.
65. He S., Atkinson C., Qiao F. et al. A complement- dependent balance between hepatic ischemia/reperfu- sion injury and liver regeneration in mice. I. Clin. Invest. 2009; И9 (8): 2304-16.
66. Marshall K.M., He S., Zhong Z. et al. Dissecting the complement pathway in hepatic injury and regeneration with a novel protective strategy. I. Exp. Med. 2014; 211 (9): 1793-805.
About Authors
Yaroustovsky Mikhail Borisovich, MD, PhD, DSc, Professor, Chief of Department of Gravitational Blood Surgery and Endoscopy; Abramyan Marina Vladimirovna, MD, PhD, Leading Research Associate; Komardina Ekaterina Viktorovna, MD, Junior Research AssociateIf you found mistakes, select text and press Alt+A